Skip to content

ORAMED PHARMACEUTICALS INC.

ORMP

CIK 0001176309

← back to feed
Revenue (TTM)
$4.02M
+49.3% YoY Q1 May 2026
Net Income (TTM)
$92.35M
+436.0% YoY Q1 May 2026
EPS Diluted (TTM)
$2.16
+412.5% YoY Q1 May 2026
Gross Margin
0.3%
Q1 May 2026
Operating Margin
-325.1%
Q1 May 2026
Net Margin
2,296.1%
Q1 May 2026
Free Cash Flow (TTM)
−$13.67M
Q1 May 2026
Cash
$13.2M
Q1 May 2026
Total Debt
$106.58M
Q1 May 2026
Shares Outstanding
40.93M sh
Q1 May 2026

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings